Phase 3Active, not recruitingAge-related condition
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2 (IRIS-2)
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial-2 (IRIS-2)
- Sponsor
- Capital Medical University (Academic or other)
- Enrolment
- 692 enrolled
- Conditions
- Acute Ischemic Stroke
- Interventions
- Tocilizumab; Placebo
- Ages
- adults, older adults
- Registry
- NCT07263776
Full record on ClinicalTrials.gov
From the registry
This study is a randomized, double-blind, placebo-controlled clinical trial. Investigators aim to assess the efficacy and safety of interleukin-6 receptor inhibitor combined with endovascular treatment in patients with acute anterior circulation large vessel occlusion stroke.
Primary outcomes
- modified Rankin Scale (mRS) score at 90 days
History
Study completion expected
Last registry update
Primary completion
Started
Registered